Mar 06, 2017 12:30 pm UTC| Business
OLDSMAR, Fla., March 06, 2017 -- Global Convergence Inc. (GCI), a leading value-added distributor of emerging, innovative and disruptive technology for global IT services and solutions, has entered into a distribution...
Mar 06, 2017 12:07 pm UTC| Business
MONTREAL, March 06, 2017 -- On February 7, 2017, the Competition Bureau of Canada made a website announcement that a company named Mega Byte Information had pled guilty and was fined $450,000 for deceptive telemarketing...
Gridsum to Announce Fourth Quarter and Full Year 2016 Financial Results on March 15, 2017
Mar 06, 2017 12:01 pm UTC| Business
BEIJING, March 06, 2017 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of cloud-based data analytics solutions in China, today announced that it plans to release its unaudited...
Gridsum to Announce Fourth Quarter and Full Year 2016 Financial Results on March 15, 2017
Mar 06, 2017 12:01 pm UTC| Business
BEIJING, March 06, 2017 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of cloud-based data analytics solutions in China, today announced that it plans to release its unaudited...
Coherus Addresses Trade Secret Action Filed by Amgen
Mar 06, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., March 06, 2017 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that Amgen has filed a trade secret action in California state court on March 3, 2017 alleging trade secret...
Coherus Addresses Trade Secret Action Filed by Amgen
Mar 06, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., March 06, 2017 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that Amgen has filed a trade secret action in California state court on March 3, 2017 alleging trade secret...
Mar 06, 2017 12:00 pm UTC| Business
Study met its primary endpoint, with TG-1101 (ublituximab) plus ibrutinib increasing Overall Response Rate (ORR) by 70% over ibrutinib alone The combination was well tolerated with a safety profile consistent with the...